I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 32% ± 10% | |
| macrophage | 5 studies | 19% ± 4% | |
| oligodendrocyte | 5 studies | 19% ± 2% | |
| natural killer cell | 4 studies | 18% ± 2% | |
| CD8-positive, alpha-beta T cell | 4 studies | 17% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 3% | |
| classical monocyte | 3 studies | 21% ± 4% | |
| non-classical monocyte | 3 studies | 24% ± 6% | |
| endothelial cell | 3 studies | 24% ± 2% | |
| ciliated cell | 3 studies | 24% ± 4% | |
| regulatory T cell | 3 studies | 17% ± 1% | |
| fibroblast | 3 studies | 19% ± 5% | |
| GABAergic neuron | 3 studies | 31% ± 2% | |
| glutamatergic neuron | 3 studies | 40% ± 5% | |
| dendritic cell | 3 studies | 27% ± 9% | |
| basal cell | 3 studies | 27% ± 3% |
